comparemela.com

Latest Breaking News On - Iagnostic codx us1897631057 - Page 1 : comparemela.com

Co-Diagnostics, Inc JV CoSara Receives Clearance from Indian Regulators for High-Risk HPV Multiplex Test

SALT LAKE CITY, Jan. 13, 2022 /PRNewswire/ Co-Diagnostics, Inc. , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,. | January 13, 2022

United statesMohal sarabhaiDwight eganCosara diagnostics pvt ltdDiagnostics inc nasdaqDiagnostics incWorld health organizationCentral drugs standard control organizationHuman papillomavirus high riskSara director mohal sarabhaiLooking statementsCo diagnosticsNc stock exchangePress releaseIagnostic codx us1897631057

Co-Diagnostics, Inc to Participate in the H C Wainwright 2022 BioConnect Virtual Conference on January 10-13

SALT LAKE CITY, Jan. 10, 2022 /PRNewswire/ Co-Diagnostics, Inc. , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced. | January 10, 2022

United statesDwight eganDiagnostics incHc wainwright coPrnewswire coConnect conferenceEastern timeLooking statementsCo diagnosticsNc stock exchangePress releaseIagnostic codx us1897631057

Co-Diagnostics, Inc Announces Completion of the Acquisition of all Assets and Intellectual Property Related to At-Home/Point-of-Care Platform

SALT LAKE CITY, Dec. 31, 2021 /PRNewswire/ Co-Diagnostics, Inc. , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,. | December 31, 2021

United statesKirk ririeDwight eganCarl wittwerConceptions incDiagnostics inc nasdaqIdaho molecular incDiagnostics incCompany scientific advisory boardIdaho molecularAdvanced conceptionsScientific advisoryLooking statementsCo diagnosticsNc stock exchangePress release

Co-Diagnostics JV CoSara Receives Clearance from Indian Regulators for ABC Multiplex Test

SALT LAKE CITY, Dec. 7, 2021 /PRNewswire/ Co-Diagnostics, Inc. , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced. | December 7, 2021

United statesMohal sarabhaiDwight eganCosara diagnostics pvt ltdDiagnostics incCentral drugs standard control organizationPrnewswire coCosara director mohalLooking statementsCo diagnosticsNc stock exchangePress releaseIagnostic codx us1897631057

vimarsana © 2020. All Rights Reserved.